在IgA病管理中的挑战:补充抑制的时代
Vladimir Tesař1, Jai Radhakrishnan2, Vivek Charu3
1Department of Nephrology, Charles University, Prague, Czech Republic.
Kidney international reports
|September 14, 2023
概括
免疫球蛋白A脏病 (IgAN) 是一种常见的脏疾病. 补充抑制剂在治疗IGAN方面表现有前途,为皮质类固醇提供潜在的替代品,并改善患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 免疫球蛋白A脏病 (IgAN) 是全球最常见的淋巴细胞疾病.
- 目前的治疗方法,包括皮质类固醇,对一些患者有局限性和显著的副作用.
- 补体系统越来越多地被认为是其在IgAN病变发生中的作用.
研究的目的:
- 审查补充系统在IGAN中的作用.
- 评估补充剂抑制剂对临床实践的潜在影响.
- 识别IGAN管理中的知识缺口和研究机会.
主要方法:
- 关于IGAN病理生理学和补充系统参与的文献综述.
- 对补充剂抑制剂的当前临床试验数据的分析.
- 对IgAN的诊断和预后生物标志物的评估.
主要成果:
- 补充系统,特别是替代和乳素通路,对IgAN进展有显著的贡献.
- 几种补充抑制剂正在后期发展,提供潜在的向疗法.
- 了解主导补充路径对于有效治疗至关重要.
结论:
- 向补充抑制剂代表了IGAN的有希望的治疗途径,可能减少对皮质类固醇的依赖.
- 需要进一步的研究来阐明特定途径的贡献,并确定可靠的生物标志物.
- 解决目前的知识差距将优化新疗法的使用,并改善Igan患者的治疗结果.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
41
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Nephrotic Syndrome III : Nursing Management
19
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Acute Kidney Injury IV: Diagnostic Studies and Prevention
34
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34


